Cytokine treatment of macrophage suppression of T cell activation

Daniel Silberman1, Amanda Bucknum, Megan Kozlowski

  • 1Department of Biology, Rider University, Lawrenceville, NJ 08648-3099, USA.

Immunobiology
|March 3, 2009
PubMed

Insights

High Mphi:T cell ratios suppress immune responses. Interleukin-6 (IL-6) can reverse this suppression, while other cytokines worsen it, offering potential therapeutic strategies for tumors.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • High myeloid cell to T cell ratios are observed in various tumors.
  • These ratios are associated with suppressed cell-mediated immunity.
  • The retroviral superantigen Mls is used to study immune suppression.

Purpose of the Study:

  • To investigate the mechanisms of immune suppression driven by high myeloid cell to T cell ratios.
  • To explore strategies for reversing this immune suppression.
  • To understand the role of cytokines in modulating immune responses in this context.

Main Methods:

  • Utilized a model system with high myeloid cell (Mphi) to T cell ratios.
  • Administered pro-inflammatory cytokines, including Interleukin-6 (IL-6), Interleukin-3 (IL-3), and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF).
  • Measured T cell responses to the Mls superantigen and Mphi expression of specific cell surface markers.

Main Results:

  • Interferon-gamma (IFN-gamma) triggered the production of indoleamine 2,3-dioxygenase (IDO) and inducible nitric oxide synthase (iNOS), enzymes that consume arginine and tryptophan, leading to immune suppression.
  • Interleukin-6 (IL-6) treatment partially reversed the suppression of T cell responses.
  • Interleukin-3 (IL-3) and GM-CSF exacerbated immune suppression.
  • GM-CSF treatment increased Mphi expression of CD80, a ligand for immune-suppressive receptors B7H1 and CTLA-4.

Conclusions:

  • High Mphi:T cell ratios suppress immunity via IFN-gamma-induced enzymes.
  • IL-6 shows potential for reversing immune suppression.
  • IL-3 and GM-CSF worsen suppression, highlighting complex cytokine interactions.
  • Targeting these pathways may offer strategies to restore anti-tumor immunity.